Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Current Assets: 2010-2025

Historic Current Assets for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $609.5 million.

  • BIO-TECHNE's Current Assets fell 6.02% to $609.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.5 million, marking a year-over-year decrease of 6.02%. This contributed to the annual value of $608.3 million for FY2025, which is 1.48% down from last year.
  • BIO-TECHNE's Current Assets amounted to $609.5 million in Q3 2025, which was up 0.20% from $608.3 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Current Assets high stood at $648.6 million for Q3 2024, and its period low was $510.6 million during Q2 2021.
  • In the last 3 years, BIO-TECHNE's Current Assets had a median value of $610.6 million in 2024 and averaged $611.9 million.
  • In the last 5 years, BIO-TECHNE's Current Assets rose by 18.60% in 2022 and then decreased by 6.02% in 2025.
  • BIO-TECHNE's Current Assets (Quarterly) stood at $590.2 million in 2021, then decreased by 4.24% to $565.2 million in 2022, then climbed by 4.50% to $590.6 million in 2023, then grew by 7.45% to $634.6 million in 2024, then fell by 6.02% to $609.5 million in 2025.
  • Its last three reported values are $609.5 million in Q3 2025, $608.3 million for Q2 2025, and $627.2 million during Q1 2025.